SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-24-069038
Filing Date
2024-08-14
Accepted
2024-08-14 16:15:20
Documents
1
Period of Report
2024-08-12

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3929
  Complete submission text file 0001213900-24-069038.txt   5341
Mailing Address 15150 AVENUE OF SCIENCE SUITE 200 SAN DIEGO CA 92128
Business Address
Townsend John (Reporting) CIK: 0001511906 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40582 | Film No.: 241208015

Mailing Address 4300 EL CAMINO REAL, SUITE 210 LOS ALTOS CA 94022
Business Address 4300 EL CAMINO REAL, SUITE 210 LOS ALTOS CA 94022 650-384-0642
Unicycive Therapeutics, Inc. (Issuer) CIK: 0001766140 (see all company filings)

IRS No.: 813638692 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)